Advertisement
Screener

Processa Pharmaceuticals, Inc. (PCSA) Notes Payable

2.8 / 5 stars · 68/120 Roast Me

Processa Pharmaceuticals, Inc. Notes Payable

Processa Pharmaceuticals, Inc. (PCSA) had Notes Payable of $17.57 thousand as of 2021-03-31, per its 10-Q filed 2021-05-13.

Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable

us-gaap:NotesPayable · last filed 2022-03-30

  • 2021-03-31: Notes Payable $17.57K.
  • 2020-12-31: Notes Payable $44.88K.
  • 2020-09-30: Notes Payable $72.13K.
  • 2020-06-30: Notes Payable $90.26K.
Period endNotes Payable
2021-03-31$17.57K
10-Q · filed 2021-05-13
2020-12-31$44.88K
10-K · filed 2022-03-30
2020-09-30$72.13K
10-Q · filed 2020-11-12
2020-06-30$90.26K
10-Q · filed 2020-08-05
2017-09-29$1.94M
10-K/A · filed 2019-04-08
2017-06-30$1.69M
10-Q · filed 2017-10-04
2017-03-31$1.61M
10-Q · filed 2017-10-04
2016-12-31$1.61M
10-K · filed 2017-09-25
2016-09-30$1.61M
10-Q · filed 2017-09-08
2016-06-30$1.61M
10-Q · filed 2017-08-30
2016-03-31$1.38M
10-Q · filed 2017-08-07
2015-12-31$1.37M
10-K · filed 2017-06-19
2014-09-30$1.82M
10-Q · filed 2014-11-13
2014-06-30$1.25M
10-Q · filed 2014-08-19
2014-03-31$728.91K
10-Q · filed 2014-05-14
2013-06-30$2.00M
10-Q/A · filed 2013-09-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Pulmatrix, Inc. (PULM)United States$0.006B
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59